Clinical Trial Results

Showing: All studies [change]
Condition: Alzheimer's 25 trials found
New Search
Filter
Trial Phase
Study Type
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
PHASE3INTERVENTIONAL Irvine, California +4 more
RECRUITING
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
PHASE3INTERVENTIONAL Long Beach, California +4 more
RECRUITING
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
PHASE3INTERVENTIONAL Fullerton, California +4 more
RECRUITING
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
PHASE2INTERVENTIONAL Long Beach, California +4 more
RECRUITING
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
PHASE2INTERVENTIONAL Baltimore, Maryland
RECRUITING
Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease
PHASE2INTERVENTIONAL Stuart, Florida +4 more
RECRUITING
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
PHASE1, PHASE2INTERVENTIONAL Irvine, California +4 more
RECRUITING
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease
PHASE2INTERVENTIONAL New York, New York
RECRUITING
Open-label Extension Study in Participants With Early Alzheimer's Disease
PHASE2INTERVENTIONAL Maitland, Florida +4 more
RECRUITING
A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration
PHASE1INTERVENTIONAL Anaheim, California +4 more
RECRUITING
Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study
NAINTERVENTIONAL Los Angeles, California
RECRUITING
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
N/AOBSERVATIONAL Columbus, Ohio
RECRUITING
Wake Forest Alzheimer's Disease Clinical Core
N/AOBSERVATIONAL Winston-Salem, North Carolina
RECRUITING
A Postmarketing Study of Lecanemab for the Treatment of Participants With Alzheimer's Disease
N/AOBSERVATIONAL Nutley, New Jersey
RECRUITING
A Postmarketing Study of LEQEMBI in South Korean Participants With Alzheimer's Disease
N/AOBSERVATIONAL Nutley, New Jersey
RECRUITING
Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies
N/AOBSERVATIONAL Phoenix, Arizona
RECRUITING
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
PHASE2, PHASE3INTERVENTIONAL Murrieta, California +4 more
RECRUITING
ACP-204 in Adults With Alzheimer's Disease Psychosis
PHASE2, PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
PHASE3INTERVENTIONAL Homewood, Alabama +4 more
RECRUITING
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
PHASE3INTERVENTIONAL Homewood, Alabama +4 more
RECRUITING
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type